Hepatic drug-metabolizing activities in rats after 14 days of oral administration of the human immunodeficiency virus-type 1 protease inhibitor ritonavir (ABT-538).
- 1 May 1996
- journal article
- Vol. 24 (5) , 615-7
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: